FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma
Oncologist - United States
doi 10.1634/theoncologist.2019-0098
Full Text
Open PDFAbstract
Available in full text
Date
March 26, 2019
Authors
Publisher
Alphamed Press